Canada's government on Monday halted the use of the AstraZeneca vaccine for its citizens under the age of 55, stating concerns of potential risks.
The National Advisory Committee on Immunisation that recommended the halt cited new data from Europe that shows that the risk of having blood clots is now comparatively higher in those who have received the AstraZeneca vaccine. The data says that the risk of blood clots being developed has now increased to 1 in 100,000. Earlier the risk of having blood clots was 1 in 1 million.
The officials further informed that most of the individuals that developed blood clots were women under the age of 55, and their fatality is as high as 40%.